From California to Massachusetts and soon, perhaps, to New Jersey, marijuana has been legalized, creating an estimated $16 billion industry that is expected to more than double in size by 2021. The cannabis industry is increasingly front and center in the minds of entrepreneurs and investors alike. However, no industry is exempt from risk, and those servicing, operating or investing in the medical and recreational cannabis sectors are faced with a particularly complex regulatory environment.
Drawing from the depth of CSG’s experienced attorneys across a myriad of disciplines, our Cannabis Law Group is uniquely positioned to help the sector’s stakeholders navigate regulatory complexity, understand their rights and capitalize on this promising field.
CSG’s Cannabis Law Group helps address a full range of issues in support of the medical and recreational cannabis sectors, including:
- Compliance and corporate governance
- Government and regulatory affairs
- Trademark and copyright
- Banking and finance
- Raising and deploying capital
- Real estate and land use
For real-time insight from CSG’s Cannabis Law Group exploring the evolution of New Jersey’s cannabis policies and its impact on the state’s business community, please visit our CannaBiz Law Blog.
Disclaimer: Using, possessing, distributing and/or selling marijuana is illegal under federal law, regardless of any state law. Businesses and individuals should be aware that compliance with state law does not assure compliance with federal law. No legal advice we give is intended to provide any guidance or assistance in violating federal law.